Pharmaceutical Working Group Go back »

The Pharmaceutical Working Group is comprised of 38 foreign pharmaceutical manufacturing companies. All members are committed to cooperating closely with Chinese healthcare stakeholders, in order to establish a competitive healthcare system which serves all Chinese patients. As such, the Working Group strongly welcomes the initiatives made for the long-term, which will substantially benefit both Chinese patients and the Chinese economy. The technology transferred from Europe further demonstrates the commitment these companies make in supporting China’s goal to become an innovative society by 2020.

  • Chair: Ms. Yingrong Du
  • Vice Chair: Ms. Li Ye, Mr. Xuan Cui

Related Lobby Actions View all »

2017-09-28

Comments on Shanghai FDA's Trial Administrative Measures on Medical Representative Registration

Read more

2017-09-15

Comments on CDE's Catalogue of Marketed Drugs in China (Draft for Comments)

Read more

Related EURObiz articles

You are currently not a member of this Working Group.

Join this Working Group

Chamber contact
Xiaochen Ni
Xiaochen Ni

Beijing

Xiaochen Ni
Xiaochen Ni

Shanghai

Quick jump to:

Back to overview